tiprankstipranks
Karuna Therapeutics (KRTX)
NASDAQ:KRTX
US Market

Karuna Therapeutics (KRTX) Cash flow

457 Followers

Karuna Therapeutics Cash Flow

KRTX's free cash flow for Q3 2023 was $-110.63M. For the 2023 fiscal year, KRTX's free cash flow was decreased by $-124.97M and operating cash flow was $-110.00M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -353.52M$ -228.01M$ -100.88M$ -69.86M$ -30.92M$ -15.38M
Investing Cash Flow
$ -559.38M$ -586.39M$ -22.69M$ -89.65M$ -174.34M$ -5.12M
Financing Cash Flow
$ 468.89M$ 855.78M$ 277.57M$ 3.66M$ 405.28M$ 27.58M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.26B$ 248.59M$ 207.21M$ 53.20M$ 209.05M$ 9.03M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---$ 0.00$ 404.90M$ 15.88M
Issuance Of Debt
---$ 0.00$ 3.13M$ 11.70M
Repayment Of Debt
------
Free Cash Flow
$ -355.93M$ -228.92M$ -103.95M$ -70.28M$ -31.04M$ -15.51M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Karuna Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis